ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM
Report
- Report Number
- 1226348-2017-00084
- Event Type
- Injury
- Date Received
- June 28, 2017
- Date of Event
- July 18, 2012
- Report Date
- June 11, 2017
- Manufacturer
- CODMAN AND SHURTLEFF, INC
- Product Code
- NJE
- PMA / PMN Number
- H60001
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MO, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THIS SUBMISSION IS RELATED TO A LITERATURE ARTICLE DISCOVERED IN AN EFFORT TO SUPPORT THE CER SUBMISSION PROCESS, AS SUCH, THE ASSOCIATED TIME FRAME OF EVENT DATES INCLUDES BUT IS NOT LIMITED TO 20 YEARS. THESE ARTICLES ARE BEING REVIEWED ON A MONTHLY BASIS FOR SAFETY SIGNALS AND WILL BE FOLLOWED BY MONTHLY TRENDING ASSESSMENTS AS WELL AS PMS REVIEWS. EVENTS THAT CAPTURED SPECIFIC PATIENT DEVICE OR PROCEDURE INFORMATION ARE LISTED IN INDIVIDUAL COMPLAINTS. ARTICLE ATTACHED TO THIS MDR: KADKHADOYAN, Y., ET AL. (2012) RHODES, N., BLACKBURN, S. COMPARISON OF ENTERPRISE WITH NEUROFORM STENT-ASSISTED COILING OF INTRACRANIAL ANEURYSMS. AJR 2013; 200:872¿878. DATE OF EVENT, PRODUCT CODE, AND LOT NUMBER COULD NOT BE OBTAINED FROM THE AUTHOR. UDI: UNKNOWN PART NUMBER, ATTEMPTS TO OBTAIN PRODUCT PART NUMBER WERE UNSUCCESSFUL, UDI UNAVAILABLE. THIS IS AN INITIAL/FINAL MDR REPORT. CONCLUSION: THE PRODUCT WAS NOT AVAILABLE FOR ANALYSIS. IN ADDITION, THE LOT NUMBER WAS NOT AVAILABLE; THEREFORE, A DHR COULD NOT BE PERFORMED. STROKE AND THROMBOSIS IS A POTENTIAL EVENT THAT CAN OCCUR WITH THE ENTERPRISE STENT AND CEREBRAL STENTING PROCEDURES AND IS LISTED IN THE INSTRUCTIONS FOR USE (IFU). THE ROOT CAUSE OF THE EVENT COULD NOT BE DETERMINED; HOWEVER, PROCEDURAL FACTORS, VESSEL CHARACTERISTICS, CONCOMITANT DEVICES, PHARAMACOLOGICAL FACTORS AND PATIENT CONDITION MAY HAVE CONTRIBUTED TO THIS EVENT. SINCE THERE WAS NO EVIDENCE OF MANUFACTURING ISSUES RELATED TO THE EVENT, NO CORRECTIVE ACTIONS WILL BE TAKEN AT THIS TIME.
IN THE LITERATURE ARTICLE ¿COMPARISON OF ENTERPRISE WITH NEUROFORM STENT-ASSISTED COILING OF INTRACRANIAL ANEURYSMS¿ BY YASHA KADKHODAYAN, NICHOLAS RHODES, SPIROS BLACKBURN, COLIN P. DERDEYN, DEWITTE T. CROSS, III, CHRISTOPHER J. MORAN, PUBLISHED AJR 2013; 200:872¿878, IT WAS REPORTED THAT THERE WERE ADVERSE EVENTS AND TECHNICAL COMPLICATIONS ASSOCIATED WITH THE USE OF UNKNOWN ENTERPRISE STENTS. ONE OF THE TIA PATIENTS PRESENTED WITH POSTPROCEDURAL CONFUSION AND DYSARTHRIA, WHICH RESOLVED OVER THE NEXT DAY. INTRAOPERATIVELY, SHE HAD A SMALL IN-STENT THROMBUS, WHICH IMPROVED WITH INTRAARTERIAL ABCIXIMAB (REOPRO, CENTOCOR/ELI LILLY). THERE WERE NO PROCEDURAL DEATHS. PER THE ARTICLE, ENTERPRISE STENT DEPLOYMENT SUCCESS WAS HIGH (108 OF 115 ATTEMPTS, 93.9%) WITH 102 ANEURYSMS RECEIVING A STENT. THE COILING MICROCATHETER WAS INSERTED INTO THE ANEURYSM BEFORE STENT DEPLOYMENT IN 70 OF 115 CASES (60.9%); NO STENT MOVEMENT GREATER THAN 1 MM WAS OBSERVED IN THESE CASES. THE JAILING TECHNIQUE, WHICH HAS BEEN USED SINCE THE BEGINNING OF OUR STENT-COILING EXPERIENCE, WAS PREFERENTIALLY USED FOR SMALLER ANEURYSMS, GENERALLY LESS THAN 3¿4 MM IN DIAMETER, CONSIDERED A HIGHER RISK TO CATHETERIZE THROUGH STENT INTERSTICES. TWO PROCEDURES WERE STAGED TO ALLOW ENDOTHELIALIZATION OF THE STENT IN THE SETTING OF PERCEIVED STENT INSTABILITY, AND THE PATIENTS RETURNED AFTER 8 WEEKS FOR COILING IN A DELAYED FASHION THROUGH THE STENT. THREE ENTERPRISE STENTS WERE PLACED TO TACK DOWN COIL TAILS; ONE WAS PLACED TO COVER A STRETCHED COIL. FIVE WERE DEPLOYED AFTER NEUROFORM PLACEMENT FAILED, AND FIVE WERE DEPLOYED THROUGH A PREVIOUSLY PLACED NEUROFORM THAT WOULD NOT RETAIN COILS. NO ADDITIONAL PATIENT, PROCEDURE OR DEVICE INFORMATION WAS PROVIDED FOR THE EVENTS CAPTURED IN THIS COMPLAINT AND NO ADDITIONAL INFORMATION COULD BE OBTAINED FROM THE AUTHOR.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 454335 | ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM | INTRACRANIAL NEUROVASCULAR STENT | NJE | CODMAN AND SHURTLEFF, INC | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |